(Note: Cadre Holdings, Inc., re-filed its IPO filing in an S-1/A dated Sept. 10, 2021. On Oct. 28, Cadre amended that filing by posting terms. Cadre Holdings withdrew its first IPO in an SEC filing dated Aug. 27, 2021. Cadre postponed its IPO on Aug. 5, 2021, the morning that its stock was expected to start trading on the New York Stock Exchange, “due to market conditions.” The postponed IPO’s terms were 7.14 million shares at a price range of $16 to $19. That IPO was expected to trade on Aug. 5, 2021.)

For over 55 years, we have been a global leader in the manufacturing and distribution of safety and survivability equipment for first responders. Our equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations.  We sell a wide range of products, including body armor, explosive ordnance disposal equipment and duty gear through both direct and indirect channels. In addition, through our owned distribution, we serve as a one-stop shop for first responders providing equipment we manufacture as well as third-party products, including uniforms, optics, boots, firearms and ammunition. 

Our target end user base includes domestic and international first responders such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians (“EMT”), fishing and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State (“DoS”), U.S. Department of Defense (“DoD”), U.S. Department of Interior (“DoI”), U.S. Department of Justice (“DoJ”), U.S. Department of Homeland Security (“DHS”), U.S. Department of Corrections (“DoC”) and numerous foreign government agencies in over 104 countries.

Note: Revenue (presented as net sales in the prospectus) and net income figures are for the last 12 months that ended June 30, 2021.

(Note: Cadre Holdings upsized its IPO at pricing on Nov. 3, 2021, to 6 million shares, up from 5.77 million in the prospectus, and priced the IPO at $13 – the mid-point of its $12-to-$14 range – to raise